Lanza, Donald C.
FL,
United States
2025 Rank: 118872
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Otorhinolaryngology
SubField 2:
Allergy
Rank in SubField 1: 326 out of 52045 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 118872 | 124813 |
| Total Cites | 7526 | 8515 |
| H-index | 42 | 45 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 38 | 43 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 1319 | 1376 |
| Number of Single+First+Last Authored Papers | 71 | 71 |
| Total Cites to Single+First+Last Authored Papers | 3393 | 3636 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6070 | 6658 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.28 |
| Self-Citation Percentage |
11.61%
|
|
Lanza, Donald C.
Sinus and Nasal Institute of Florida,
United States
2024 Rank: 110657
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Otorhinolaryngology
SubField 2:
Allergy
Rank in SubField 1: 298 out of 49389 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 110657 | 118605 |
| Total Cites | 7268 | 8226 |
| H-index | 42 | 43 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 38 | 43 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 1301 | 1358 |
| Number of Single+First+Last Authored Papers | 71 | 71 |
| Total Cites to Single+First+Last Authored Papers | 3293 | 3533 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5835 | 6404 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.28 |
| Self-Citation Percentage |
11.65%
|
|
Lanza, Donald C.
Sinus and Nasal Institute of Florida,
United States
2023 Rank: 105862
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Otorhinolaryngology
SubField 2:
Allergy
Rank in SubField 1: 290 out of 47021 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 105862 | 112085 |
| Total Cites | 7005 | 7952 |
| H-index | 41 | 43 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 36 | 41 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 1279 | 1336 |
| Number of Single+First+Last Authored Papers | 71 | 71 |
| Total Cites to Single+First+Last Authored Papers | 3190 | 3430 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5600 | 6163 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.29 |
| Self-Citation Percentage |
11.91%
|
|
Lanza, Donald C.
Sinus and Nasal Institute of Florida,
United States
2022 Rank: 100719
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Otorhinolaryngology
SubField 2:
Allergy
Rank in SubField 1: 272 out of 45251 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 100719 | 106265 |
| Total Cites | 6579 | 7479 |
| H-index | 40 | 42 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 34 | 39 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 1231 | 1287 |
| Number of Single+First+Last Authored Papers | 71 | 71 |
| Total Cites to Single+First+Last Authored Papers | 3034 | 3269 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5244 | 5773 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.30 |
| Self-Citation Percentage |
12.03%
|
|
Lanza, Donald C.
Sinus and Nasal Institute of Florida,
United States
2021 Rank: 98982
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Otorhinolaryngology
SubField 2:
Allergy
Rank in SubField 1: 262 out of 43138 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 98982 | 104038 |
| Total Cites | 6347 | 7211 |
| H-index | 39 | 41 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 34 | 39 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 1192 | 1245 |
| Number of Single+First+Last Authored Papers | 71 | 71 |
| Total Cites to Single+First+Last Authored Papers | 2946 | 3172 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5058 | 5565 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.30 |
| Self-Citation Percentage |
11.98%
|
|
Lanza, Donald C.
Sinus and Nasal Institute of Florida,
United States
2020 Rank: 91476
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Otorhinolaryngology
SubField 2:
Allergy
Rank in SubField 1: 246 out of 33662 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 91476 | 97140 |
| Total Cites | 5972 | 6739 |
| H-index | 39 | 40 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 31 | 36 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 1156 | 1207 |
| Number of Single+First+Last Authored Papers | 69 | 69 |
| Total Cites to Single+First+Last Authored Papers | 2818 | 3039 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4717 | 5152 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.31 |
| Self-Citation Percentage |
11.38%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.